Identification of HLA haplotype in tumor cells, after relapse following allogeneic hematopoietic stem cell transplantation from a haploidentical donor for hematological malignancy
Not Applicable
Recruiting
- Conditions
- relpased hematological malignancy after haploidnetical HSCT
- Registration Number
- JPRN-UMIN000029097
- Lead Sponsor
- Division of Hematology, Saitama Medical Center, Jichi Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
None.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the rate of the loss of mismatched haplotype in tumor cells after relapse
- Secondary Outcome Measures
Name Time Method